Newest
News
-
Sercomm Unlocks Deployment Flexibility for Cost-effective Fiber Expansion
Sercomm\'s I-TEMP 10G PON SFP+ ONU is Now Certified with Harmonic\'s cOS PON OLT Portfolio ATLANTA,Sept. 23,2024-- Sercomm Corporation (TWSE: 5388),a leading provider of telecom and broadband equipmen
09-25
Details -
#PlumeStrong Cycling Challenge 2024 Surpasses Goal by Raising over €610.000 for Street Child to Develop Secondary Schools in Sierra Leone
PALO ALTO,Calif.,Sept. 23,2024-- Plume completed its fourth annual #PlumeStrong Cycling Challenge (#PSCC24) – a 5-stage 824 km route from Zurich,Switzerland to Venice,Italy that took place from Septe
09-25
Details -
China's leading Gifts & Home Fair in October to feature more than 4,500 suppliers
SHENZHEN,China,Sept. 24,2024-- Asia\'s largest consumer productssourcing trade fair The 32nd China (Shenzhen) International Gifts and Home Products Fair (hereinafter referred to as " SZ Gift Fair
09-25
Details -
Hillhouse-Backed Ascentium Launches Global Business Services Platform in Singapore
Lennard Yong Appointed as Founding Management and Group CEO to Spearhead Ascentium\'s Global Expansion
09-25
Details -
Revolutionizing Last Mile: ZelosTech's Autonomous Delivery Vehicles Drive $29 Billion Delivery Future
The urban last mile delivery market is a critical segment within the logistics industry, currently facing significant challenges such as high costs, low efficiency, and difficulties in hiring personnel. These issues have created a pressing need for innovative solutions that can empower businesses to overcome these obstacles and optimize their operations. ZelosTech, with its cutting-edge autonomous driving technology, is poised to address these challenges head-on.
09-24
Details -
2024 China Perfume and Fragrance White Paper Unveiled in Suzhou, China
09-24
Details -
“The Third 919 World Living Tea Day” cultural activity was successfully held in Yuxi, China
09-24
Details -
Zhihe Bio Showcases China's Ceramide Strength at In-cosmetics Latin America 2024
09-23
Details -
Kangpu Completed Bridging Clinical Study of KPG-818 in China
HEFEI,China,Sept. 20,2024-- Kangpu Biopharmaceuticals,a clinical-stage company based in Hefei,announced today that the Company has successfully completed a bridging clinical study of KPG-818 in healt
09-21
Details -
Unveiling of NYO3 in Vitafoods Asia: Filling the Gap in the Southeast Asian Market with the Strength of an Omega-3 Expert Brand
09-21
Details
